Skip to main content

Table 6 Comparison of different pathological patterns in the neoadjuvant group

From: Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III–IVA esophageal squamous cell carcinoma post-surgery

 

Ulceratice

Mushroom

Constrictive

Medullary

Numbers

23

5

5

1

pCR

8 (34.78%)

0

1 (20.00%)

0

MPR

2 (8.70%)

2 (40.00%)

0

0

CR

8 (34.78%)

0 (

1 (20.00%)

0

PR

11 (47.83%)

5 (100.00%)

4 (80.00%)

1 (100.00%)

SD

4 (11.39%)

0

0

0

PD

0

0

0

0

TRG0

8 (34.78%)

0

1 (20.00%)

0